3,6,9,12,15,18,21-Heptaoxatricosanedioic acid, 97%, 250mg

3-Chloro-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 5g

N-tert-Butylcyclopropanesulfonamide, 95.0%, 10g

1-(3-Methoxy-5-(trifluoromethyl)pyridin-2-yl)ethanone, 97%, 5g

(S)-6-METHOXYCHROMAN-3-CARBOXYLIC ACID, 95.0%, 500mg

5-((2-(Methylamino)-5-nitrophenyl)amino)-5-oxopentanoic acid, 95.0%, 500mg

4-t-Butylpyridine-2-carbonitrile, 10g

2-Fluoro-5-methoxybenzonitrile, 98.0%, 1g

n-undecano, mínimo 95 %, para síntesis, 100 ml, envase de vidrio

1-[1-(3-methoxypropyl)pyrrolidin-3-yl]methanamine, 95.0%, 1g

5-(4-Methylphenyl)-5-oxovaleric acid, 95.0%, 100g

2-(1H-Pyrazol-4-yl)-ethanol, 95.0%, 10g

3-(4-Bromo-1H-pyrazol-1-yl)piperidine hydrochloride, 97%, 10g